Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Medpace Hldgs Q3 EPS $3.86 Beats $3.52 Estimate, Sales $659.903M Beat $640.997M Estimate

Author: Benzinga Newsdesk | October 22, 2025 04:15pm
Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $3.52 by 9.69 percent. This is a 28.24 percent increase over earnings of $3.01 per share from the same period last year. The company reported quarterly sales of $659.903 million which beat the analyst consensus estimate of $640.997 million by 2.95 percent. This is a 23.74 percent increase over sales of $533.317 million the same period last year.

Posted In: MEDP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist